Amundi’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Buy
197,364
+14,744
+8% +$292K ﹤0.01% 1053
2026
Q1
$3.51M Buy
182,620
+33,787
+23% +$666K ﹤0.01% 1032
2025
Q4
$2.82M Buy
148,833
+14,609
+11% +$271K ﹤0.01% 1112
2025
Q3
$2.4M Buy
134,224
+10,687
+9% +$200K ﹤0.01% 1040
2025
Q2
$2.28M Sell
123,537
-19,852
-14% -$352K ﹤0.01% 1057
2025
Q1
$2.53M Buy
143,389
+6,457
+5% +$109K ﹤0.01% 1093
2024
Q4
$2.35M Buy
136,932
+342
+0.3% +$6.25K ﹤0.01% 1150
2024
Q3
$2.44M Buy
136,590
+678
+0.5% +$11.4K ﹤0.01% 1111
2024
Q2
$2.09M Sell
135,912
-12,072
-8% -$172K ﹤0.01% 1094
2024
Q1
$1.99M Sell
147,984
-13,302
-8% -$184K ﹤0.01% 1157
2023
Q4
$2.21M Sell
161,286
-26,352
-14% -$374K ﹤0.01% 1169
2023
Q3
$2.67M Buy
187,638
+9,272
+5% +$119K ﹤0.01% 1107
2023
Q2
$2.11M Buy
178,366
+10,726
+6% +$122K ﹤0.01% 1146
2023
Q1
$1.9M Buy
167,640
+16,280
+11% +$201K ﹤0.01% 1162
2022
Q4
$1.98M Buy
151,360
+22,362
+17% +$285K ﹤0.01% 1189
2022
Q3
$1.7M Buy
128,998
+9,640
+8% +$142K ﹤0.01% 1170
2022
Q2
$1.7M Sell
119,358
-45,497
-28% -$608K ﹤0.01% 1102
2022
Q1
$2.29M Buy
164,855
+32,418
+24% +$444K ﹤0.01% 1100
2021
Q4
$1.88M Buy
132,437
+8,098
+7% +$115K ﹤0.01% 1199
2021
Q3
$1.83M Sell
124,339
-368,527
-75% -$6.22M ﹤0.01% 1207
2021
Q2
$8.97M Buy
+492,866
New +$8.78M 0.01% 873

Other funds holding SBRA

Amundi's SBRA Position: Q2 2026 in Review

Amundi increased its Sabra Healthcare REIT (SBRA) stake by 8.1% in Q2 2026, buying an estimated $292K and bringing the position to 197,364 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

Amundi first reported a position in SBRA in Q2 2021 and has held it in 21 quarters since. The position peaked at $8.97M in Q2 2021. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Amundi held 197,364 shares of Sabra Healthcare REIT worth $3.85M as of Q2 2026.
  • Amundi bought 14,744 Sabra Healthcare REIT shares in Q2 2026, an estimated $292K.
  • Sabra Healthcare REIT made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1053 holding.
  • Amundi first reported a position in Sabra Healthcare REIT in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Sabra Healthcare REIT position peaked at $8.97M in Q2 2021.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.